Evolution and Controllability of Cancer Networks: A Boolean Perspective

Area of Science:

• Computational Biology
• Systems Biology
• Cancer Research

Background:

• Cancer is a robust system that progresses through stages with increasing aggressiveness.
• Understanding gene transitions between cancer stages is crucial for developing effective therapies.

Purpose of the Study:

• To propose a novel Boolean network model (BoolSpace) for analyzing cancer progression.
• To identify genes driving transitions between cancer stages by "flipping" and "editing" interactions.

Main Methods:

• Developed a Boolean state space model using protein-interaction and gene-expression data.
• Formulated a minimization problem (min flip) to identify key transition genes.
• Applied the BoolSpace model to human pancreatic and breast tumors, and rat spinal-cord injury models.

Main Results:

• Identified rewiring in cell-cycle and DNA-damage repair pathways in tumors.
• Found that serine/threonine kinases act as biological switches between cancer stages.
• Observed distinct gene sets flipped during initial and final cancer progression stages.

Conclusions:

• Cancer robustness may stem from a "passing of the baton" mechanism between genes across different stages.
• This stage-specific gene involvement allows tumors to evade targeted therapies.
• Effective cancer therapy may require targeting a "cover set" of these stage-specific genes.